According to Precedence Research, the global gRNA market size is expected to grow from USD 708.92 million in 2025 to nearly ...
Gene therapy could be a permanent cure for many life-threatening hereditary diseases, and this will only help in the treatment of genetic diseases and cancer ...
The "Plant Breeding and CRISPR Plants - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Plant Breeding and CRISPR Plants was valued at US$21 ...
Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...
21hon MSN
Indian Scientists Create Protein That Lights Up During Gene Editing, May Aid Cancer Treatment
Scientists from Kolkata-based Bose Institute have created GlowCas9--a CRISPR protein that lights up while performing gene ...
Morning Overview on MSN
Programmable CRISPR cuts stem cell timing from months to weeks
Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...
CRISPR Therapeutics (NASDAQ:CRSP) gains visibility as biotechnology activity aligns with broader movements across the Nasdaq ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
In the latest allocation of European funding for cutting-edge research, ETH Zurich scientists have performed exceptionally ...
Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.
MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback